研究者業績

熊野 恵城

クマノ ケイキ  (KUMANO KEIKI)

基本情報

所属
武蔵野大学 薬学部 教授
学位
博士(医学)(1999年3月 東京大学)

J-GLOBAL ID
201801003635316249
researchmap会員ID
B000327851

学歴

 2

論文

 103
  • K Shimizu, S Chiba, K Kumano, N Hosoya, T Takahashi, Y Kanda, Y Hamada, Y Yazaki, H Hirai
    JOURNAL OF BIOLOGICAL CHEMISTRY 274(46) 32961-32969 1999年11月  査読有り
    The Delta/Serrate/LAG-2 (DSL) domain containing proteins are considered to be ligands for Notch receptors, However, the physical interaction between DSL proteins and Notch receptors is poorly understood, In this study, we cloned a cDNA for mouse Jagged1 (mJagged1), To identify the receptor interacting with mJagged1 and to gain insight into its binding characteristics, we established two experimental systems using fusion proteins comprising various extracellular parts of mJagged1, a "cell" binding assay and a "solid-phase" binding assay. mJagged1 physically bound to mouse Notch2 (mNotch2) on the cell surface and to a purified extracellular portion of mNotch2, respectively, in a Ca2+-dependent manner. Scatchard analysis of mJagged1 binding to BaF3 cells and to the soluble Notch2 protein demonstrated dissociation constants of 0.4 and 0.7 nM, respectively, and that the number of mJagged1-binding sites on BaF3 is 5,548 per cell. Furthermore, deletion mutant analyses showed that the DSL domain of mJagged1 is a minimal binding unit and is indispensable for binding to mNotch2, The epidermal growth factor-like repeats of mJagged1 modulate the affinity of the interaction, with the first and second repeats playing a major role, Finally, solid-phase binding assay showed that Jagged1 binds to Notch1 and Notch3 in addition to Notch2, suggesting that mJagged1 is a ligand for multiple Notch receptors.
  • 熊野恵城, 平井久丸
    実験医学 17 1144-1148 1999年  招待有り
  • T Takahashi, K Yamada, T Tanaka, K Kumano, M Kurokawa, T Takahashi, N Hirano, H Honda, S Chiba, K Tsuji, Y Yazaki, T Nakahata, H Hirai
    BLOOD 91(12) 4509-4515 1998年6月  査読有り
    Ex vivo expansion of hematopoietic stem cell (HSC) is an attractive technology for its potency of a variety of clinical applications. Such a technology has been achieved to Some extent with combinations of various cytokines or continuous perfusion cultures. However, much more improvement is required especially for expansion of primitive hematopoietic progenitors, We propose here a novel molecular approach that might have the potential to compensate the current expansion. We designed an adenovirus vector to transiently express human epidermal growth factor receptor (EGFR), which is known to transduce only a mitogenic, but not a differentiation signal to mouse bone marrow cells on human purified CD34(+) peripheral blood (PB) cells, and tried to expand these cells with EGF ex vivo. Because we found that exposure of CD34(+) PB cells to cytokines induced surface expression of adenovirus-internalization receptor and rendered these cells permissive to adenovirus infection, we infected these cells with the adenovirus vector carrying EGFR gene in the presence of cytokines. Two-color flow cytometric analysis demonstrated that 60.3% +/- 22.4% of CD34(+) cells expressed the adenovirus-mediated EGFR. Moreover, long-term culture-initiating cell assay showed that adenovirus vector could transduce more primitive progenitors. Subsequently, we tried to expand these cells in suspension culture with EGF for 5 days. Methylcellulose clonal assay showed that EGF induced 5.0- +/- 2.4-fold proliferation of the colony-forming unit pool during 5 days of expansion. The simple procedure of efficient adenovirus gene delivery to immature hematopoietic cells proved promising, and this technique was potentially applicable for a novel strategy aiming at ex vivo expansion of hematopoietic progenitors. (C) 1998 by The American Society of Hematology.

MISC

 45
  • 並河 健, 菅野 渉平, 齋賀 一歩, 石垣 和彦, 田中 聖道, 鷲尾 隆太, 山内 壮作, 熊野 恵城, 上野 博夫
    診断病理 35(1) 34-40 2018年1月  
    6ヵ月20日の男児。在胎34週5日、体重1,726gで出生した。Down症候群・TAMと診断され、Ara-Cによる加療を受けたが、日齢185日に呼吸状態が悪化し死亡した。末梢血には日齢1〜15日に芽球が出現し、一旦は消失するが、剖検時の骨髄では20%以上の芽球を認めた。それらはMPO(+)かつCD61(-)で、FAB分類ではDown症候群に典型的なM7ではなくM2を示唆するものであった。肺高血圧症と複合要因により呼吸不全に至った症例であった。その経過について考察を交えて報告する。(著者抄録)
  • Takashi Matsukawa, Tomotaka Yamamoto, Takashi Toya, Akihito Shinohara, Yasuhito Nanya, Sachiko Seo, Keiki Kumano, Motoshi Ichikawa, Yuji Takahashi, Hiroyuki Ishiura, Jun Mitsui, Masaki Tanaka, Mineo Kurokawa, Shoji Tsuji
    ANNALS OF NEUROLOGY 80 S201-S201 2016年10月  
  • Shuichi Ohe, Toshihiro Tanaka, Hirotsugu Yanai, Yoshihiro Komai, Taichi Omachi, Shohei Kanno, Kiyomichi Tanaka, Kazuhiko Ishigaki, Kazuho Saiga, Naohiro Nakamura, Haruyuki Ohsugi, Yoko Tokuyama, Naho Atsumi, Hiroko Hisha, Naoko Yoshida, Keiki Kumano, Fumikazu Yamazaki, Hiroyuki Okamoto, Hiroo Ueno
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 472(1) 292-292 2016年3月  
  • 田中 敏宏, 駒井 資弘, 徳山 陽子, 矢内 洋次, 大江 秀一, 大町 太一, 田中 聖道, 石垣 和彦, 金 桂花, 厚海 奈穂, 菅野 渉平, 吉田 真子, 比舎 弘子, 熊野 恵城, 上野 博夫
    Cytometry Research 24(Suppl.) 58-58 2014年6月  
  • 比舎 弘子, 田中 敏宏, 菅野 渉平, 徳山 陽子, 駒井 資弘, 大江 秀一, 矢内 洋次, 大町 太一, 石垣 和彦, 田中 聖道, 厚海 奈穂, 吉田 直子, 熊野 恵城, 上野 博夫
    日本病理学会会誌 103(1) 274-274 2014年3月  

書籍等出版物

 2

主要な講演・口頭発表等

 30

担当経験のある科目(授業)

 20

共同研究・競争的資金等の研究課題

 22